Non-HFE hemochromatosis: genetics, pathogenesis, and clinical management

Curr Gastroenterol Rep. 2005 Feb;7(1):71-80. doi: 10.1007/s11894-005-0069-y.

Abstract

Recent advances in our understanding of iron metabolism and the epidemiology of iron overload disorders have shown that hereditary forms of hemochromatosis can result from mutations in several iron metabolism genes other than HFE, including Hamp, HJV, TFR2, and SCL40A. These "non-HFE" forms of hemochromatosis are much rarer than HFE-related hemochromatosis but exhibit a similar phenotype, and with the exception of ferroportin disease, a similar pattern of inheritance and parenchymal iron accumulation. Therefore, these diseases can be thought of as variant forms of a primary hepatic iron overload syndrome; thus, a unified approach can be used for evaluation and diagnosis. Management generally consists of periodic phlebotomies until iron is depleted.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Child
  • Female
  • Genetic Predisposition to Disease
  • Hemochromatosis / genetics*
  • Hemochromatosis / mortality
  • Hemochromatosis / physiopathology
  • Hemochromatosis / therapy*
  • Hemochromatosis Protein
  • Histocompatibility Antigens Class I / genetics*
  • Humans
  • Iron / blood*
  • Iron Metabolism Disorders / genetics
  • Iron Metabolism Disorders / physiopathology
  • Iron Metabolism Disorders / therapy
  • Male
  • Membrane Proteins / genetics*
  • Mutation
  • Phenotype
  • Phlebotomy / methods*
  • Prognosis
  • Risk Assessment
  • Sex Factors
  • Survival Analysis
  • Treatment Outcome

Substances

  • HFE protein, human
  • Hemochromatosis Protein
  • Histocompatibility Antigens Class I
  • Membrane Proteins
  • Iron